You are here: Industry Insights > Japan

News List

Gilead gets approval for Jyseleca (filgotinib) in Japan for rheumatoid arthritis expresspharma
September 27, 2020
Gilead Japan will hold marketing authorisation of Jyseleca in Japan while Eisai will be responsible for product distribution.
Takeda to sell consumer healthcare unit in Japan for $2.28bn pharmaceutical-technology
August 25, 2020
Takeda Pharmaceutical has signed an agreement to sell its Consumer Healthcare unit to investment firm The Blackstone Group for JPY242bn ($2.28bn).
Bushu Pharmaceuticals Unveils Major Expansion Program contractpharma
August 19, 2020
Japanese CDMO will invest $100 million to expand capacity and portfolio, Koichiro Matsumoto named president and CEO.
Medipal Holdings Partners with Cryoport contractpharma
August 10, 2020
Cryoport Inc. and Medipal Holdings Corporation have announced a multi-year strategic business alliance agreement to create an integrated regenerative medicine supply chain solution in Japan.
Pharma Secretary urges closer cooperation between India, Japan in pharma, med devices sector expresspharma
August 10, 2020
There is a need for India and Japan to work together to tap the opportunities provided by the pharma and medical devices industry in India, said P D Vaghela, Secretary, Department of Pharmaceuticals.
Cryoport, Medipal Partner on Supply Chain Solutions for Japanese Market contractpharma
August 05, 2020
Will partner to provide integrated distribution solutions for specialty cell and gene therapies that demand stringent temperature control.
Pfizer and BioNTech to supply 120 million Covid-19 vaccine doses to Japan pharmaceutical-technology
August 04, 2020
Pfizer and BioNTech have entered an agreement with Japan’s Ministry of Health, Labour and Welfare (MHLW) to provide 120 million doses of their BNT162 Covid-19 vaccine candidate.
Japan approves dexamethasone to treat Covid-19 patients pharmaceutical-technology
July 23, 2020
The Japanese health ministry has approved a low-cost and widely available steroid drug, dexamethasone, for the treatment of patients suffering from Covid-19.
Beroni Group to Supply COVID-19 Antibody Test Kit to Japan americanpharmaceuticalreview
July 21, 2020
Beroni Group is collaborating with Forsitech and Standard Capital to supply its SARS-CoV-2 total antibody detection kit for clinical testing in the Japanese market.
Japan Approves Remdesivir For Use On Severe COVID-19 Patients forbes.com
May 08, 2020
Japan approved the antiviral drug Remdesivir of the Gilead Sciences for the treatment of severe COVID-19 patients.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page